A sophisticated cybercrime operation is targeting the global supply chain by hacking freight companies to intercept cargo shipments. Security researchers have identified multiple criminal groups using this method, with Apple products among the likely high-value targets. The time-sensitive nature of
With MIT reporting staggering 95% failure rates for AI initiatives, timing emerges as the critical factor separating successful implementations from expensive disappointments. Business leaders across industries reveal why cadence, psychology, and change management matter more than technology itself
Geopolitical disruption is costing companies significant revenue, yet most are still relying on outdated mitigation strategies. The data reveals a dangerous gap between what companies do and what actually works.
NUBURU’s $1.5M investment in Orbit marks a fundamental transformation from hardware manufacturer to defense technology integrator. The staged acquisition reveals a sophisticated strategy to combine drone intelligence with real-time command software. This pivot positions NUBURU for the growing $3B op
Standard Chartered CEO Bill Winters predicts nearly all global transactions will eventually move to blockchain ledgers. The banking executive sees this as a complete rewiring of the financial system during Hong Kong FinTech Week discussions.
Europe’s venture capital landscape is undergoing a dramatic transformation as AI and defense technologies attract record investment. The continent’s tech ecosystem is maturing rapidly, with profound implications for global competition.
This week brings two landmark decisions that could redefine presidential trade powers and executive compensation. The outcomes will influence everything from global supply chains to how tech giants retain visionary leaders.
When startup founders intentionally provoke controversy to gain attention, the short-term gains may come with long-term consequences. The Cluely controversy reveals the risks of rage bait marketing in tech.
In a dramatic pharmaceutical showdown, Pfizer has filed a lawsuit against Novo Nordisk over a competing $9 billion bid for obesity drug developer Metsera. The legal battle signals intensifying competition in the lucrative weight loss treatment market.
The debate over whether renewables raise or lower electricity prices is fundamentally flawed. Both sides are missing the bigger picture about how energy costs are distributed across the system and who bears the burden of transition.
